Bill118th CongressFiled Apr 19, 2023Health
H.Res. 309
Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Apr 19, 2023)
This resolution expresses the sense of the House of Representatives that the Food and Drug Administration (FDA) has the authority to review and approve drugs pursuant to its own expertise, and that recent court decisions blocking the FDA's approval of mifepristone (which is used in medication abortion) violate congressional intent with respect to the FDA's authority.
What just happenedApr 19, 2023
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Manning, Kathy E. [D-NC-6](D-NC)Sponsor
48 cosponsors48 D
48cosponsors1committees3actions
- Introduced in HouseApr 19, 2023
- Apr 19, 2023IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Apr 19, 2023IntroReferralIntro-H
Introduced in House
- Apr 19, 2023IntroReferral1000
Introduced in House